Moderna (MRNA) Down as Pfizer Paxlovid EUA May Fuel Competition

Moderna’s (MRNA) COVID-19 vaccine may face stiffer competition following the FDA’s emergency approval of an oral COVID-19 pill, Pfizer’s Paxlovid, which may result in lower sales.

Leave a comment

Your email address will not be published. Required fields are marked *